New IHE publication on Multi-indication and Combination Pricing and Reimbursement of Pharmaceuticals27 Apr 2018
Many pharmaceuticals are effective in multiple indications and the degree…
New IHE publication22 Feb 2018
New IHE publication on the cost-effectiveness of canagliflozin vs. dapagliflozin…
Peter Lindgren – new head of IHE on January 1, 201819 Dec 2017
After 10 years as CEO of The Swedish Institute for…
Michael Willis represents IHE at ISPOR in Glasgow10 Nov 2017
IHE, together with others from the Mount Hood Challenge in…
IHE presented study on excess costs of non-infectious comorbidities among people living with HIV at the HIV & Hepatitis Nordic Conference in Stockholm September 27-293 Oct 2017
People living with HIV (PLHIV) have an increased risk of…
New IHE publication on end-of-life premium in cancer22 Aug 2017
The results provide some support for the use of an…
IHE Report on patients’ access to new cancer treatments in the UK18 Jul 2017
Today, IHE releases a IHE report titled “Comparator report on…
New IHE publication on long-term sustained effect of biologic psoriasis treatment28 Jun 2017
The study was based on data from repeated consultations of…
IHE´s Board of Directors – New member21 Jun 2017
We are happy to announce that Anders Lönnberg – life…
Doctoral thesis9 Jun 2017
IHEs Sofie Persson successfully defended her doctoral thesis on socioeconomic…